Location
United States, North America
Cheque size
$25M - $60M
Investment Stage
Series A
Series B
Focus Areas
BioTech
About Investor
Widya Mulyasasmita is a Senior Principal, Healthcare at B Capital Group. Her investing focus is biotech at growth venture stages, particularly Series A and Series B. Her typical investment range is $25.0M to $60.0M. She holds a PhD in bioengineering and has operator experience, including co-founding OliLux Biosciences and working in new ventures and biotech company-building roles.
Previous investments
Triumvira Immunologics
45M |2022
OncoMyx Therapeutics
50M |2021
Viron
50M |2021
Similar Investors
FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,SN
Scott Nolan
United States, North America
$500K - $150M
Seed
,Series A
,MH
Matt Huang
United States, North America
$1M - $100M
Seed
,Series A
,GS
Glenn Solomon
United States, North America
$250K - $25M
Seed
,Series A
,HM
Howard Morgan
United States, North America
$100K - $60M
Seed
,Series A
,DC
Daniel Chen
United States, North America
$50K - $200M
Series B
,Is this Your Profile?
If you have any updates, please fill out our form.